Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 26/10/20 → 8/01/21 |
Keywords
- SARS CoV2
- COVID-19
- Clinical trial
Clinical Trial Phase
- Phase II
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SARS-CoV-2 Neutralizing Antibody BGB-DXP593 in Patients With Mild-to-Moderate COVID
- McMahon, James (Primary Chief Investigator (PCI))
- Roney, Janine (Project Manager)
Project: Research